4//SEC Filing
Wyant Alyssa 4
Accession 0001127602-18-021562
CIK 0001472091other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:12 PM ET
Size
5.1 KB
Accession
0001127602-18-021562
Insider Transaction Report
Form 4
Wyant Alyssa
SVP Regulatory Affairs
Transactions
- Award
Stock Option (Right To Purchase)
2018-06-19+99,534→ 99,534 totalExercise: $1.10→ Common Stock (99,534 underlying)
Footnotes (2)
- [F1]These options shall become exercisable upon the achievement of certain performance or time based criteria.
- [F2]These options expire on the third anniversary of the vesting date.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001698765
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:12 PM ET
- Size
- 5.1 KB